Preferable Transplant Site for Hepatocyte Transplantation in a Rat Model

Area of Science:

• Hepatology
• Transplantation Immunology
• Surgical Procedures

Background:

• Hepatocyte transplantation (HTx) commonly uses intraportal injection.
• Instant blood-mediated inflammatory reaction (IBMIR) impacts islet transplantation engraftment.
• Alternative transplant sites are explored for HTx to mitigate IBMIR, but data is limited.

Purpose of the Study:

• To determine the optimal transplant site for hepatocyte transplantation (HTx).
• To compare the efficacy of nine different transplantation sites for HTx.

Main Methods:

• Hepatocytes were transplanted into nine sites in analbuminemic rats.
• Evaluated serum albumin levels, immunohistochemistry (albumin, TUNEL, BrdU), and in vivo imaging.
• Compared outcomes across intraportal (IPO), intrasplenic (IS), and other sites.

Main Results:

• Intraportal (IPO) injection yielded significantly higher serum albumin levels (p < .0001).
• Hepatocyte proliferation (BrdU) in the liver was comparable between IPO and intrasplenic (IS) groups.
• Graft function in the IS group appeared primarily due to hepatocyte migration to the liver.

Conclusions:

• Intraportal injection is the most efficient site for hepatocyte transplantation (HTx).
• Alternative sites may rely on hepatocyte migration to the liver for function.
• This study validates intraportal injection as the superior method for HTx.